Home Science Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease

Largest DxA investment to date supports development of Alamar’s ARGO™ DX System and future in vitro diagnostic tests
Author Of article :
MoMath Brings Prime Numbers to a Prime New Location
After outgrowing its original home, the National Museum of Mathematics has added new exhib…









